As of 2024-12-15, the Intrinsic Value of Immunovant Inc (IMVT) is
-11.00 USD. This IMVT valuation is based on the model Peter Lynch Fair Value.
With the current market price of 26.28 USD, the upside of Immunovant Inc is
-141.87%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-11.00 USD
Intrinsic Value
IMVT Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-11.00 - -11.00 |
-11.00 |
-141.87% |
| P/E |
(45.60) - (42.30) |
(49.29) |
-287.6% |
| DDM - Stable |
(10.07) - (20.16) |
(15.11) |
-157.5% |
| DDM - Multi |
(6.56) - (10.39) |
(8.06) |
-130.7% |
IMVT Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
3,857.38 |
| Beta |
0.51 |
| Outstanding shares (mil) |
146.78 |
| Enterprise Value (mil) |
3,384.44 |
| Market risk premium |
4.60% |
| Cost of Equity |
16.56% |
| Cost of Debt |
5.00% |
| WACC |
10.78% |